| 查看: 763 | 回复: 9 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
Science：注射强力抗体抑制血液中HIV病毒
|
|||
|
12月23日，来自美国NIH的科学家们在国际学术期刊上发表了一项最新研究进展，他们报告称注射一种叫做VRC01的强效抗体就能够抑制未接受抗逆转录病毒治疗的HIV携带者血液中的HIV病毒水平。研究人员还发现通过静脉注射或皮下注射方式将VRC01抗体注入病毒携带者体内具有非常好的安全性和耐受性，并且注入的抗体能够在病人血液中保持较长时间。 Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection http://stm.sciencemag.org/content/7/319/319ra206 Passive aggression for HIV Antibodies that neutralize HIV could add to the therapeutic arsenal to prevent and treat disease. Lynch et al. have now tested one such antibody—VRC01—in HIV-infected individuals. Although little difference was observed in viral reservoir in individuals on antiretroviral therapy, plasma viremia was reduced in untreated subjects with a single infusion of VRC01, preferentially suppressing neutralization-sensitive strains. Passive immunization with neutralizing antibodies could therefore aid in viral suppression in HIV-infected individuals. Abstract Passive immunization with HIV-1–neutralizing monoclonal antibodies (mAbs) is being considered for prevention and treatment of HIV-1 infection. As therapeutic agents, mAbs could be used to suppress active virus replication, maintain suppression induced by antiretroviral therapy (ART), and/or decrease the size of the persistent virus reservoir. We assessed the impact of VRC01, a potent human mAb targeting the HIV-1 CD4 binding site, on ART-treated and untreated HIV-1–infected subjects. Among six ART-treated individuals with undetectable plasma viremia, two infusions of VRC01 did not reduce the peripheral blood cell–associated virus reservoir measured 4 weeks after the second infusion. In contrast, six of eight ART-untreated, viremic subjects infused with a single dose of VRC01 experienced a 1.1 to 1.8 log10 reduction in plasma viremia. The two subjects with minimal responses to VRC01 were found to have predominantly VRC01-resistant virus before treatment. Notably, two subjects with plasma virus load <1000 copies/ml demonstrated virus suppression to undetectable levels for over 20 days until VRC01 levels declined. Among the remaining four subjects with baseline virus loads between 3000 and 30,000 copies, viremia was only partially suppressed by mAb infusion, and we observed strong selection pressure for the outgrowth of less neutralization-sensitive viruses. In summary, a single infusion of mAb VRC01 significantly decreased plasma viremia and preferentially suppressed neutralization-sensitive virus strains. These data demonstrate the virological effect of this neutralizing antibody and highlight the need for combination strategies to maintain virus suppression. |
回复此楼» 猜你喜欢
富马酸比索洛尔杂质机理与制备难点探讨
已经有0人回复
-
【分享】福多司坦杂质降解反应｜QC 检验交流
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有194人回复
-
【交流】地塞米松磷酸钠的几个化学反应以及有关物质质控心得
已经有0人回复
-
【质量控制交流】维生素 C 杂质研究分享，脱氢抗坏血酸质控要点
已经有0人回复
-
赛洛多辛有关物质开发，分享几个实操难点
已经有0人回复
-
求助几篇文献
已经有3人回复
-
黄体酮有关物质｜4 类常见降解反应溯源小结
已经有0人回复
-
【讨论】美罗培南杂质，不愧是培南里的难题大户，踩坑太多了
已经有0人回复
-
【讨论】利托那韦，做有关物质的同行来聊聊，这个品种到底有多难啃？
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 食物也能摧毁肝脏：我们是怎样吃出肝功能衰竭甚至肝癌的？
已经有0人回复
- 和元生物2015年基因功能研究方法与实践培训班开始报名啦！
已经有4人回复
- 从纳米技术到外太空：盘点2014年度十大科技发明
已经有1人回复
- PD-1抗体：癌症免疫疗法的研发竞赛
已经有14人回复
- （最新至2013.10）纳米技术与生物学交叉领域研究进展（中文简报带英文摘要）
已经有343人回复
- Science奇文：假论文换来真接收
已经有15人回复
- Nature：全览细胞培养技术最新前沿
已经有20人回复
- 注射剂协会（PDA)正在修订无菌药品的技术报告
已经有5人回复
- 分析化学最新期刊汇总第一季（10篇）
已经有28人回复
- 在《Science》上发表论文，难，还是不难？
已经有16人回复
- 在《Science》上发表论文
已经有14人回复
- 中国高校发表Science文章最新排名
已经有17人回复
- 【转帖】《自然—神经科学》：针灸止痛存在科学原理
已经有8人回复
- 【转帖】《自然—神经科学》：针灸止痛存在科学原理
已经有1人回复
9楼2016-01-10 22:44:07
10楼2016-01-15 11:20:45
简单回复
2015-12-30 09:12
回复
